In the current study, we demonstrate that CD24 level in peripheral blood leukocytes (PBLs) can be used as a potential marker for the detection of CR neoplasia and examine the possible implications of CD24 genetic variants in the genetic predisposition to CRC. Here, CD24 is linked to neoplasm.